FIGURE

Fig. 6

ID

ZDB-FIG-211008-13

Publication

Yu et al., 2021 - Neuroprotective effects of Ginkgo biloba dropping pills in Parkinson's disease

Other Figures

All Figure Page

Back to All Figure Page

Fig. 6

GBDP treatment decreased the Bax/Bcl-2 ratio and increased Akt/GSK3β levels in MPP+-treated human SH-SY5Y cells. (A) Western blot assay of p-Akt, Akt, p-GSK3β, GSK3β, Bax, and Bcl-2. (B–D) Ratio of p-Akt, Akt, p-GSK3β, GSK3β, Bax, and Bcl-2 band intensities. ∗P < 0.05, ∗∗P < 0.001. (E) SH-SY5Y cells were pre-treated with the GSK3β inhibitor, CHIR-99021 (10 μM) for 2 h and subsequently exposed to 2 mM MPP+ and different concentrations of GBDP or EGb 761. After 24 h, cells underwent an MTT assay. ∗∗∗P < 0.0001, compared with the control group. ###P < 0.0001, compared with the MPP+ group. △P < 0.05, △△P < 0.001, △△△P < 0.0001. Data were analyzed by one-way ANOVA followed by Dunnett’s test. n = 3 per group. GAPDH: glyceraldehyde-3-phosphate dehydrogenase.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ J Pharm Anal